Novartis Makes A Bearish Move As One Of Its Bread-And-Butter Drugs Misses The company's second biggest product missed sales expectations. Shares look likely to undercut a buy zone.
Abbott Laboratories Sheds Nearly 5% On A Rare Guidance Miss The company issued a light outlook for 2025 organic sales growth despite beating second-quarter forecasts.
MEDTRONIC PLC (NYSE:MDT) – A Potential Undervalued Opportunity in Healthcare MEDTRONIC PLC (
NYSE:MDT ) appears undervalued with strong profitability, a solid dividend, and stable financials, making it a candidate for value investors.
MEDTRONIC PLC (NYSE:MDT) – A Reliable Dividend Stock Worth Considering MEDTRONIC PLC (
NYSE:MDT ) offers a solid 3.18% dividend yield, strong profitability, and reasonable valuation, making it a candidate for dividend investors. The company has a reliable payout history and decent financial health.
5 Robotics Stocks to Buy for the Future of Automation Robotics adoption is accelerating globally, with AI, automation, and real-time data processing reshaping industries from healthcare to manufacturing.
Bank Of America Loves These 8 Stocks For Third Quarter—And Says To Dump These 2 Fast Bank of America names its highest-conviction stock ideas for Q3 2025—8 Buys and 2 Underperforms. Boeing, Cisco, and Datadog top the list.
Medtronic Stock Is Climbing Friday: What's Going On? CMS proposed Medicare coverage for Medtronic's renal denervation therapy for high blood pressure, signaling a key step toward broader adoption.
Medtronic Names CFO For New Diabetes Company Ahead Of Intended Spin-Off Chad Spooner’s appointment will be effective July 14, and he will be responsible for overseeing the Finance function for Medtronic Diabetes and supporting initiatives.
Merit Medical Names Medtronic Veteran Martha Aronson As Next CEO, Projects Strong Outlook Merit Medical appoints Medtronic veteran Martha Aronson as CEO, projecting strong Q2 revenue above estimates.
Merit Medical Stock Soars After Hours As Better-Than-Expected Q2 Guidance Outweighs CEO Exit The company expects second-quarter revenue to grow by as much as 14% year-over-year, with foreign exchange headwinds expected to trim approximately $2.3 million from the top line.
Why Diabetes Titans Dexcom, Tandem, Insulet Just Hit The Skids A proposal would cut Medicare reimbursements for some medical devices using a competitive bidding process.
3 Safe Buy-and-Hold Dividend Stocks With Strong Balance Sheets These 3 dividend stocks offer strong balance sheets, low debt, and reliable payouts, making them solid long-term picks for income investors
Want Decades of Passive Income? 5 Stocks to Buy Now and Hold Forever Forever is a tricky word in the stock market, but these stocks are as safe as they come and will pay you to hold them.
FDA Sounds Alarm After 33 Injuries Tied To Medtronic Device Malfunction FDA highlights risks from recalled Medtronic devices tied to esophageal injuries and faulty cannulas, with serious health concerns and product warnings issued.
Abbott, Dexcom Draw Retail Buzz As RFK Jr. Urges Americans To Embrace Health Wearables Retail sentiment surged on Stocktwits, with message volume jumping 1,600% for Abbott and 750% for Dexcom.
Texas Instruments Stock: Congress Likes It, Should You Too? Texas Instruments is well-positioned to meet the increasing demand for domestically produced semiconductor products across sectors and industries.
